In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

PPD buys genomic discovery tool from Ingenex

Executive Summary

Pharmaceutical Product Development, a contract research organization, acquired from Titan Pharmaceuticals' majority-owned gene therapy subsidiary Ingenex a drug discovery platform called the GSX System for about $8.7mm cash.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • Product Purchase

Related Companies

Advertisement
UsernamePublicRestriction

Register